Thrombin Generation and Gestational Outcome

In total 120 pregnant women's with history of recurrent miscarriages, are planned for inclusion in this trial. After signing an informed consent a blood sample will be obtained from each participant. The investigators will measure the thrombin generation in plasma assessed by the calibrated automated thrombogram (CAT). The relation between pregnancy outcome and thrombin measurements will be determined

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thrombophilia Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Haemek medical center

Afula, 18101, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age > 18
signed inform consent
first trimester
two early miscarriages(before week 10) or one later abortions (after week 10)

Exclusion criteria

Chronic treatment with aspirin or other anticoagulants

Treatment and study plan

Primary outcomes

pregnancy outcome

Time frame: 2 years

Sponsors and collaborators

Lead sponsor

HaEmek Medical Center, Israel

Other

Registry information

Official study title

Thrombin Generation and Gestational Outcome in Women With Recurrent Pregnancy Loss

Important dates

Study start: 2013
Primary completion: 2016
Study completion: 2017
First posted: May 15, 2014
Registry last updated: Mar 1, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed